Anti-inflammatories in Alzheimer's disease-potential therapy or spurious correlate?
Ontology highlight
ABSTRACT: Epidemiological evidence suggests non-steroidal anti-inflammatory drugs reduce the risk of Alzheimer's disease. However, clinical trials have found no evidence of non-steroidal anti-inflammatory drug efficacy. This incongruence may be due to the wrong non-steroidal anti-inflammatory drugs being tested in robust clinical trials or the epidemiological findings being caused by confounding factors. Therefore, this study used logistic regression and the innovative approach of negative binomial generalized linear mixed modelling to investigate both prevalence and cognitive decline, respectively, in the Alzheimer's Disease Neuroimaging dataset for each commonly used non-steroidal anti-inflammatory drug and paracetamol. Use of most non-steroidal anti-inflammatories was associated with reduced Alzh
SUBMITTER: Rivers-Auty J
PROVIDER: S-EPMC7585697 | biostudies-literature | 2020
REPOSITORIES: biostudies-literature
ACCESS DATA